Uso de bedinvetmab para controlar el dolor crónico en un perro con artrosis

Abstract

Osteoarthritis is currently the most commonly known joint condition in dogs. Its challenging classification and pain control have been the focus of studies and drug testing aimed at improving the quality of life for patients. This study aimed to evaluate the use of a canine monoclonal antibody for managing osteoarthritis pain, utilizing the pain guideline-approved scale as an evaluative method answered by the owner. Additionally, we sought to observe the response over one month of treatment. It presents a more practical therapeutic approach, well-received by owners, with fewer side effects compared to the use of anti-inflammatories.